“…The most promising current technologies, as outlined in several clinical trials cited in this review, include basic fibrin mesh scaffolds in gel form for seeding of MSCs; however, technologies for improving MSC efficiency in wound healing continue to emerge, such as recent studies for microsphere delivery in wound gel. 114 MSC therapy also holds promise in improving wound healing outcomes in other wound care settings, such as surgical wounds or burns. 115,116 Ongoing studies into MSC immunomodulation and wound support in other wound models (myocardial infarction, brain, long bone defects, and others) may continue support advanced wound care research with insights into novel biomaterials and beneficial properties of MSCs in cell therapy.…”